Research Lab Results for Alzheimer's disease
Alzheimer's Disease Research CenterLab WebsitePrincipal Investigator:
Marilyn Albert, Ph.D.
The goal of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) is to accelerate the d...iscovery of new treatments that are directed at the basic mechanisms of disease, and to hasten the time when effective treatments for AD and related disorders become a reality. We have a strong commitment to basic research regarding the underlying mechanisms of Alzheimer's Disease and related disorders, and how this may translate into effective treatment. We perform clinical research seeking to identify medications to delay or treat the symptoms of dementia. We also provided many educational programs for family members and professionals. view moreResearch Areas: dementia, Alzheimer's disease
Esther Oh LabPrincipal Investigator:
Esther Oh, M.D., Ph.D.
The Esther Oh Lab is interested in developing biological markers for pre-clinical stages of Alz...heimer's disease (AD). Our current research involves using transgenic models of AD to develop peripheral injections of monoclonal antibodies against amyloid-beta as a tool to detect a level of amyloid-beta that would be correlative to the amyloid-beta level in the brain. view moreResearch Areas: amyloid-beta, dementia, Alzheimer's disease, monoclonal antibodies
Jun Hua LabLab WebsitePrincipal Investigator:
Jun Hua, Ph.D.
Radiology and Radiological Science
Dr. Hua's research has centered on the development of novel MRI technologies for in vivo functi...onal and physiological imaging in the brain, and the application of such methods for studies in healthy and diseased brains. These include the development of human and animal MRI methods to measure functional brain activities, cerebral perfusion and oxygen metabolism at high (3 Tesla) and ultra-high (7 Tesla and above) magnetic fields. He is particularly interested in novel MRI approaches to image small blood and lymphatic vessels in the brain. Collaborating with clinical investigators, these techniques have been applied 1) to detect functional, vascular and metabolic abnormalities in the brain in neurodegenerative diseases such as Huntingdon's disease (HD), Parkinson's disease (PD), Alzheimer's disease (AD) and mental disorders such as schizophrenia; and 2) to map brain functions and cerebrovascular reactivity for presurgical planning in patients with vascular malformations, brain tumors and epilepsy. view moreResearch Areas: imaging technology development, applications in brain diseases
Lee Martin LaboratoryLab WebsitePrincipal Investigator:
Lee Martin, Ph.D.
In the Lee Martin Laboratory, we are testing the hypothesis that selective vulnerability--the p...henomenon in which only certain groups of neurons degenerate in adult onset neurological disorders like amyotrophic lateral sclerosis and Alzheimer's disease--is dictated by brain regional connectivity, mitochondrial function and oxidative stress. We believe it is mediated by excitotoxic cell death resulting from abnormalities in excitatory glutamatergic signal transduction pathways, including glutamate transporters and glutamate receptors as well as their downstream intracellular signaling molecules.Research Areas: ALS, neurodegeneration, selective vulnerability, cell death, Alzheimer's disease
We are also investigating the contribution of neuronal/glial apoptosis and necrosis as cell death pathways in animal (including transgenic mice) models of acute and progressive neurodegeneration. We use a variety of anatomical and molecular neurobiological approaches, including neuronal tract-tracing techniques, immunocytochemistry, immunoblotting, antipeptide antibody production, transmission electron microscopy and DNA analysis to determine the precise regional and cellular vulnerabilities and the synaptic and molecular mechanisms that result in selective neuronal degeneration.
Philip Wong LabLab WebsitePrincipal Investigator:
Philip Wong, Ph.D.
The Philip Wong Lab seeks to understand the molecular mechanisms and identification of new ther...apeutic targets of neurodegenerative diseases, particularly Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). Taking advantage of discoveries of genes linked to these diseases (mutant APP and PS in familial AD and mutant SOD1, dynactin p150glued ALS4and ALS2 in familial ALS), our laboratory is taking a molecular/cellular approach, including transgenic, gene targeting and RNAi strategies in mice, to develop models that facilitate our understanding of pathogenesis of disease and the identification and validation of novel targets for mechanism-based therapeutics. Significantly, these mouse models are instrumental for study of disease mechanisms, as well as for design and testing of therapeutic strategies for AD and ALS. view moreResearch Areas: neurodegenerative disorders, ALS, genomics, pathogenesis, Alzheimer's disease
Psychiatric NeuroimagingPrincipal Investigator:
Arnold Bakker, Ph.D., M.A.
Psychiatry and Behavioral Sciences
Psychiatric Neuroimaging (PNI) is active in neuropsychiatric research using imaging methods suc...h as MRI, fMRI, PET and DTI to understand the mechanisms and brain networks underlying human cognition. PNI faculty have published hundreds of papers on a variety of brain disorders which include but are not limited to Alzheimer's disease, Parkinson's disease, bipolar disorder, and eating disorders. Faculty in the division have been awarded numerous peer-reviewed grants by the National Institutes of Health, foundations and other funding organizations.Research Areas: brain disorders